Modulation of Hyperandrogenic Anovulation Through Fenugreek Seeds

• To collect data, written consent was obtained from the hospital and university administration.
• After receiving signed informed consent, the data were collected.

• Screening: The participants who meet the study inclusion criteria were enrolled and FSH/LH, Insulin resistance or lipid profile samples were taken by the hospital lab assistant. The participants will be requested not to alter their routine physical activity.
• Allocation: Following screening, participants were divided evenly into three groups: experimental group (1, 2) and one control group. The participants received different dosage in different experimental groups of fenugreek seeds powder) c.Follow up: A systematic communication plan will be developed in order to follow up with participants on their daily consumption of the suggested fenugreek powder through telephonic conversations. For continuous assistance there was a WhatsApp group set up where members may ask issues and get help associated with hyperandrogenic anovulation. The follow up for patients were conducted every month; baseline and after 60 days. Appointments for follow-up exams were made in order to track developments, anthropometric measurements were calculated every follow up and modify the dosage as necessary. The baseline and post study test were compared to test the hypothesis.

Inclusion criteria

• Female have been BMI more than 25
• Patients with irregular periods or hormonal imbalance
• Patients with age 15 to 25 years of young females

Exclusion criteria

• Pregnant & Lactating Women
• Any history of allergic reaction to fenugreek seeds
• Severe gastrointestinal disorders like crohn's disease
• People with liver or kidney issue